Labcorp Holdings Inc. (FRA:N6B)

Germany flag Germany · Delayed Price · Currency is EUR
220.00
-4.00 (-1.79%)
At close: Jan 29, 2026
-6.38%
Market Cap18.95B -1.8%
Revenue (ttm)11.73B +8.3%
Net Income728.89M +96.4%
EPS8.68 +98.4%
Shares Outn/a
PE Ratio25.99
Forward PE15.72
Dividend2.57 (1.17%)
Ex-Dividend DateNov 26, 2025
Volumen/a
Average Volume2
Open220.00
Previous Close224.00
Day's Range220.00 - 220.00
52-Week Range183.00 - 248.00
Betan/a
RSI50.10
Earnings DateFeb 17, 2026

About Labcorp Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target... [Read more]

Industry Medical Laboratories
Founded 1995
Employees 70,000
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol N6B
Full Company Profile

Financial Performance

In 2024, Labcorp Holdings's revenue was $13.01 billion, an increase of 6.97% compared to the previous year's $12.16 billion. Earnings were $746.00 million, an increase of 78.47%.

Financial numbers in USD Financial Statements